Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENT AND DERIVITATIVES

v3.7.0.1
FAIR VALUE MEASUREMENT AND DERIVITATIVES
9 Months Ended
Sep. 30, 2016
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENT AND DERIVATIVES

NOTE 8 – FAIR VALUE MEASUREMENT AND DERIVATIVES

 

The Company measures fair value in accordance with a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below:

 

   
Level 1 Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
Level 2 Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and
Level 3 Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

 

 

All derivatives recognized by the Company are reported as derivative liabilities on the condensed consolidated balance sheets and are adjusted to their fair value at each reporting date.  Unrealized gains and losses on derivative instruments are included in change in value of derivative liabilities on the condensed consolidated statement of operations.  

 

The following table sets forth the Company’s condensed consolidated financial assets and liabilities measured at fair value by level within the fair value hierarchy at September 30, 2016 and December 31, 2015. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 

                         
    Fair value at                  
    September 30, 2016   Level 1   Level 2   Level 3
Preferred stock embedded conversion feature   $  166,903   $  -   $  -   $  166,903
Anti-dilution provision in common stock warrants included with preferred stock      60,878      -      -      60,878
Debenture embedded conversion feature      45,171      -              -      45,171
Anti-dilution provision in common stock warrants included with debentures      23,686     -               -      23,686
Total derivatives   $  296,638   $  -   $ -   $  296,638

 

 

 

                         
    Fair value at                  
    December 31, 2015   Level 1   Level 2   Level 3
Preferred stock embedded conversion feature   $ 376,065   $  -   $  -   $ 376,065
Anti-dilution provision in common stock warrants included with preferred stock     51,203      -      -     51,203
Debenture embedded conversion feature     560,778      -              -     560,778
Anti-dilution provision in common stock warrants included with debentures     79,943     -               -     79,943
Total derivatives   $ 1,067,989   $  -   $ -   $ 1,067,989

 

There were no transfers between levels during the nine months ended September 30, 2016.

 

 As part of the Merger, the Company assumed debentures that are convertible into shares of common stock, which Anpath issued in July 2014 (see Note 7). The debentures conversion price will be adjusted depending on various circumstances. The conversion options embedded in these instruments contain no explicit limit to the number of shares to be issued upon settlement and as a result are classified as derivative liabilities under ASC 815. Additionally, the Company issued in connection with the debentures 415,000 warrants to purchase the Company’s common stock.  The conversion price will be adjusted depending on various circumstances, and as there is no explicit limit to the number of shares to be issued upon settlement they are classified as derivative liabilities under ASC 815.   

 

The terms of the convertible redeemable preferred stock (see Note 9) include an anti-dilution provision that requires an adjustment in the common stock conversion ratio should subsequent issuances of the Company’s common stock be issued below the instruments’ original conversion price of $0.26 per share, subject to certain defined excluded issuances.  In 2015 per modification agreement with the holders, the conversion price was reset to $0.21. Accordingly, we bi-furcated the embedded conversion feature, which is shown as a derivative liability recorded at fair value on the condensed consolidated balance sheets.

 

The agreement setting forth the terms of the common stock warrants issued to the holders of the convertible preferred stock (see Note 9) also includes an anti-dilution provision that requires a reduction in the warrant’s exercise price of $0.50 should the conversion ratio of the convertible preferred stock be adjusted due to anti-dilution provisions. Accordingly, the warrants do not qualify for equity classification, and, as a result, the fair value of the derivative is shown as a derivative liability on the condensed consolidated balance sheets.

 

On February 2, 2016, the two debenture holders converted a total of $40,000 of their debentures for 190,476 shares of common stock.  One of the holders converted another $31,500 in its debenture on March 11, 2016 for 150,000 shares of common stock, and then converted an additional $31,500 on June 22, 2016 for 150,000 shares of common stock.  During the three months ended September 30, 2016, the debenture holders converted an additional $167,750 of principal into 798,809 shares of common stock. Pursuant to the conversion of these debentures, the Company reclassified a total of $125,975 of derivative liabilities to additional paid in capital during the nine months ended September 30, 2016.  The changes in fair value of these derivative liabilities were recorded in the statement of operations until the date of conversion.

 

The following table presents a reconciliation of the beginning and ending balances of items measured at fair value on a recurring basis that use significant unobservable inputs (Level 3) and the related realized and unrealized gains (losses) recorded in the condensed consolidated statement of operations during the period:

 

                                 
Nine Months Ended September 30, 2016
      Preferred stock embedded conversion feature     Anti-dilution provision in common stock warrants included with preferred stock     Debenture embedded conversion feature     Anti-dilution provision in common stock warrants included with debentures     Total  
Fair value,                                 
December 31, 2015   $ 376,065     51,203     560,778     79,943     1,067,989  
Net unrealized                                
(Gain)/Loss on derivatives      (233,700)      (44,826)      (389,632)      (56,257)      (724,415)  
Purchases and issuances                                
(Sales and settlements)     24,538     54,501     (125,975)     -     (46,936)  
Fair value, September 30, 2016   $  166,903      60,878      45,171      23,686      296,638  
Changes in unrealized                                
losses, included                                
in income on                                
instruments held                                
at end of period   $ (233,700)     (44,826)     (389,632)     (56,257)     (724,415)  

 

 

The Company’s derivative liabilities are valued by using Black Scholes methods which approximate Monte Carlo Simulation methods. Where possible, the Company verifies the values produced by its pricing models to market prices. Valuation models require a variety of inputs, including contractual terms, market prices, yield curves, credit spreads, measures of volatility and correlations of such inputs. These derivative liabilities do not trade in liquid markets, and as such, model inputs cannot generally be verified and do involve significant management judgment. Such instruments are typically classified within Level 3 of the fair value hierarchy. The following assumptions were used to value the Company’s derivative liabilities at September 30, 2016: dividend yield of -0-%, volatility of 98.27 – 167.35%, risk free rates of 0.59 - 1.14% and an expected term of 0.8 years to 4.3 years.

 

During the nine months ended September 30, 2016, the Company continues to refine its estimates and has updated the volatility used in its valuation models and the underlying number of shares of common stock for the derivative warrants. The net impact of these adjustments resulted in a $117,456 increase in the fair value of derivative liabilities during the nine months ended September 30, 2016, which could have been reflected as part of the estimated fair value of these derivative liabilities at December 31, 2015. However, the Company recorded these true-up adjustments during 2016 given the inherent nature of Level 3 fair value measures.  The Company recorded a total of $724,415 and $131,530 for the change in fair value of all the Level 3 derivatives during the nine months ended September 30, 2016 and the year ended December 31, 2015, respectively.